For example, immunohistochemical analysis of HNSCC tumor xenografts after systemic administration of cetuximab demonstrated inhibition of the expression of tumor angiogenesis markers, including VEGF and Factor VIII [35]. The gene discussed is VEGFA; the disease is head and neck squamous cell carcinoma.